/CHEK
CHEK Stock - Check-Cap Ltd.
Healthcare|Medical - Diagnostics & ResearchNASDAQ
$1.61+1.90%
+$0.03 (+1.90%) • Nov 26
71
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.67
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.77
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CHEK
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.59 – $1.63
TARGET (TP)$1.85
STOP LOSS$1.48
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.46
52W High$3.13
52W Low$0.56
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-161,000 | $-212,000 | $-405,000 | $-205,000 | $-148,000 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-25,949,000 | $-19,287,000 | $-20,034,000 | $-17,321,000 | $-13,932,000 |
| Net Income | $-25,149,000 | $-17,568,000 | $-19,108,000 | $-17,202,000 | $-13,846,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-4.30 | $-3.00 | $-3.37 | $-4.13 | $-9.12 |
Company Overview
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CHEKBeat Rate
44%
Last 16 quarters
Avg Surprise
-56.3%
EPS vs Estimate
Beats / Misses
7/8
1 met exactly
Latest EPS
$-1.61
Q3 2025
EPS Surprise History
Q1 23
+5.9%
$-0.64vs$-0.68
Q2 23
No data
Q3 23
-111.1%
$-0.95vs$-0.45
Q4 23
-46.7%
$-0.44vs$-0.30
Q1 24
+26.4%
$-0.64vs$-0.87
Q2 24
+28.7%
$-0.62vs$-0.87
Q3 24
-217.3%
$-0.54vs$-0.17
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 27, 2025 | — | $-1.61 | — | — |
Q2 2025 | Jun 4, 2025 | — | — | — | — |
Q4 2024 | Oct 29, 2024 | — | — | — | — |
Q3 2024 | Sep 13, 2024 | $-0.17 | $-0.54 | -217.3% | ✗ MISS |
Q2 2024 | May 15, 2024 | $-0.87 | $-0.62 | +28.7% | ✓ BEAT |
Q1 2024 | Mar 29, 2024 | $-0.87 | $-0.64 | +26.4% | ✓ BEAT |
Q4 2023 | Nov 27, 2023 | $-0.30 | $-0.44 | -46.7% | ✗ MISS |
Q3 2023 | Aug 4, 2023 | $-0.45 | $-0.95 | -111.1% | ✗ MISS |
Q2 2023 | Apr 5, 2023 | — | $-0.71 | — | — |
Q1 2023 | Mar 31, 2023 | $-0.68 | $-0.64 | +5.9% | ✓ BEAT |
Q4 2022 | Nov 30, 2022 | $-0.90 | $-0.04 | +95.6% | ✓ BEAT |
Q3 2022 | Aug 31, 2022 | $-1.00 | $-0.80 | +20.0% | ✓ BEAT |
Q2 2022 | Jun 1, 2022 | $-1.20 | $-1.20 | 0.0% | = MET |
Q2 2022 | Apr 7, 2022 | $-0.50 | $-1.20 | -140.0% | ✗ MISS |
Q4 2021 | Nov 3, 2021 | $-1.00 | $-0.80 | +20.0% | ✓ BEAT |
Q3 2021 | Aug 5, 2021 | $-1.00 | $-1.20 | -20.0% | ✗ MISS |
Q2 2021 | May 12, 2021 | $-1.20 | $-1.00 | +16.7% | ✓ BEAT |
Q1 2021 | Mar 19, 2021 | $-1.40 | $-9.20 | -557.1% | ✗ MISS |
Q4 2020 | Nov 18, 2020 | $-1.60 | $-1.80 | -12.5% | ✗ MISS |
Q3 2020 | Aug 6, 2020 | $-2.20 | $-2.40 | -9.1% | ✗ MISS |
Latest News
Check-Cap Announces That Its Nasdaq Ticker Symbol Will Change From "CHEK" To "MBAI", Effective At Opening Of Trading On December 2, 2025
➖ NeutralBenzinga•Dec 1, 2025, 01:53 PM
Check-Cap shares are trading higher after the company and MBody AI announced a definitive merger agreement.
📈 PositiveBenzinga•Sep 15, 2025, 03:36 PM
Market-Moving News for Sept 15
➖ NeutralBenzinga•Sep 15, 2025, 11:25 AM•Also: ,
Check-Cap jumps 120% on merger with MBody AI
📈 PositiveSeeking Alpha•Sep 15, 2025, 08:46 AM
Check-Cap Entered Into Agreement, Plan Of Merger With MBody AI; Combined Company Will Be Renamed "MBody AI Ltd."; Combined Co Will Continue To Hold Check-Cap's Legacy Assets, Consisting Primarily Of Patents And Proprietary Medical Equipment
➖ NeutralBenzinga•Sep 12, 2025, 08:47 PM
Frequently Asked Questions about CHEK
What is CHEK's current stock price?
Check-Cap Ltd. (CHEK) is currently trading at $1.61 per share. The stock has moved +1.90% today.
What is the analyst price target for CHEK?
No analyst price targets are currently available for this stock.
What sector is Check-Cap Ltd. in?
Check-Cap Ltd. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the NASDAQ exchange.
What is CHEK's market cap?
Check-Cap Ltd. has a market capitalization of $0.01 billion, making it a small-cap company.
Does CHEK pay dividends?
No, Check-Cap Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACXP
Acurx Pharmaceuticals, Inc.
$3.33
Mkt Cap: $0.0B
ADIL
Adial Pharmaceuticals, Inc.
$0.24
Mkt Cap: $0.0B
BFRI
Biofrontera Inc.
$0.77
Mkt Cap: $0.0B
GBS
GBS Inc.
$0.47
Mkt Cap: $0.0B
HCWB
HCW Biologics Inc.
$1.57
Mkt Cap: $0.0B
LUCY
Innovative Eyewear, Inc.
$1.38
Mkt Cap: $0.0B
MYNZ
Mainz Biomed B.V.
$1.20
Mkt Cap: $0.0B
NRSN
NeuroSense Therapeutics Ltd.
$0.81
Mkt Cap: $0.0B
PFSA
Profusa, Inc. Common Stock
$0.12
Mkt Cap: $0.0B
SBFM
Sunshine Biopharma, Inc.
$1.39
Mkt Cap: $0.0B
Explore stocks similar to CHEK for comparison